Literature DB >> 33800955

Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations.

Kaya E Witte1,2, Oliver Hertel3,4, Beatrice A Windmöller1,2, Laureen P Helweg1,2, Anna L Höving1,5, Cornelius Knabbe2,5, Tobias Busche4, Johannes F W Greiner1,2, Jörn Kalinowski4, Thomas Noll3,4, Fritz Mertzlufft2,6, Morris Beshay2,7, Jesco Pfitzenmaier2,8, Barbara Kaltschmidt1,2,9, Christian Kaltschmidt1,2, Constanze Banz-Jansen2,10, Matthias Simon2,11.   

Abstract

Cancer stem cells (CSCs) are crucial mediators of tumor growth, metastasis, therapy resistance, and recurrence in a broad variety of human cancers. Although their biology is increasingly investigated within the distinct types of cancer, direct comparisons of CSCs from different tumor types allowing comprehensive mechanistic insights are rarely assessed. In the present study, we isolated CSCs from endometrioid carcinomas, glioblastoma multiforme as well as adenocarcinomas of lung and prostate and assessed their global transcriptomes using full-length cDNA nanopore sequencing. Despite the expression of common CSC markers, principal component analysis showed a distinct separation of the CSC populations into three clusters independent of the specific type of tumor. However, GO-term and KEGG pathway enrichment analysis revealed upregulated genes related to ribosomal biosynthesis, the mitochondrion, oxidative phosphorylation, and glycolytic pathways, as well as the proteasome, suggesting a great extent of metabolic flexibility in CSCs. Interestingly, the GO term "NF-kB binding" was likewise found to be elevated in all investigated CSC populations. In summary, we here provide evidence for high global transcriptional similarities between CSCs from various tumors, which particularly share upregulated gene expression associated with mitochondrial and ribosomal activity. Our findings may build the basis for identifying novel therapeutic strategies targeting CSCs.

Entities:  

Keywords:  cancer stem cells; endometrioid carcinoma; glioblastoma multiforme; lung adenocarcinoma; mitochondrion; nanopore sequencing; prostate adenocarcinoma; ribosome

Year:  2021        PMID: 33800955      PMCID: PMC7962028          DOI: 10.3390/cancers13051136

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  7 in total

Review 1.  S100A6 as a Constituent and Potential Marker of Adult and Cancer Stem Cells.

Authors:  Wiesława Leśniak; Anna Filipek
Journal:  Stem Cell Rev Rep       Date:  2022-07-07       Impact factor: 5.739

2.  Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling.

Authors:  Beatrice A Windmöller; Morris Beshay; Laureen P Helweg; Clara Flottmann; Miriam Beermann; Christine Förster; Ludwig Wilkens; Johannes F W Greiner; Christian Kaltschmidt; Barbara Kaltschmidt
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

3.  The Diminishment of Novel Endometrial Carcinoma-Derived Stem-like Cells by Targeting Mitochondrial Bioenergetics and MYC.

Authors:  Laureen P Helweg; Beatrice A Windmöller; Leonie Burghardt; Jonathan Storm; Christine Förster; Nils Wethkamp; Ludwig Wilkens; Barbara Kaltschmidt; Constanze Banz-Jansen; Christian Kaltschmidt
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

Review 4.  Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review.

Authors:  Barbara Kaltschmidt; Kaya E Witte; Johannes F W Greiner; Florian Weissinger; Christian Kaltschmidt
Journal:  Biomedicines       Date:  2022-01-25

Review 5.  NF-κB in neurodegenerative diseases: Recent evidence from human genetics.

Authors:  Barbara Kaltschmidt; Laureen P Helweg; Johannes F W Greiner; Christian Kaltschmidt
Journal:  Front Mol Neurosci       Date:  2022-08-02       Impact factor: 6.261

6.  A Personalized Genomics Approach of the Prostate Cancer.

Authors:  Sanda Iacobas; Dumitru A Iacobas
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

Review 7.  Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?

Authors:  Constanze Banz-Jansen; Laureen P Helweg; Barbara Kaltschmidt
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.